BioMarin Pharmaceutical saw the highest growth of 1.12% in patent filings in April and 1.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.12% and grants by 0.28%. GlobalData’s DataBook provides a comprehensive analysis of BioMarin Pharmaceutical‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
BioMarin Pharmaceutical has been focused on protecting inventions in European Patent Office(EPO) with five publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 18% filings and 12% grants. The United States(US), European Patent Office(EPO), Chile(CL), and Denmark(DK) patent Office are among the top ten patent offices where BioMarin Pharmaceutical is filings its patents. Among the top granted patent authorities, BioMarin Pharmaceutical has 12% of its grants in European Patent Office(EPO).
Roche and Johnson & Johnson could be the strongest competitors for BioMarin Pharmaceutical
Patents related to cell & gene therapy and rare diseases lead BioMarin Pharmaceutical's portfolio
BioMarin Pharmaceutical has the highest number of patents in cell & gene therapy followed by, rare diseases and genomics. For cell & gene therapy, nearly 57% of patents were filed and no patents were granted in Q2 2024.
Cryopyrin-associated periodic syndromes related patents lead BioMarin Pharmaceutical portfolio followed by lysosomal storage disorder, and hemophilia
BioMarin Pharmaceutical has highest number of patents in cryopyrin-associated periodic syndromes followed by lysosomal storage disorder, hemophilia, hemophilia a (factor viii deficiency), and mucopolysaccharidosis.
For comprehensive analysis of BioMarin Pharmaceutical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
